established in 1998 in shenzhen, china, hepalink is a leading multinational biopharmaceutical company dual-listed in hong kong and mainland china. driven by patient’s unmet needs, hepalink is striving to fulfill its mission of bringing safe and effective therapies and services to patients around the world.
yearsestablished in 1998 in shenzhen
stocksdual-listed in hong kong and mainland china
countries and regionswith presence and business operations in over 40 countries and regions around the world
hepalink’s three main business segments
covering heparin industrial chain, cdmo services of large molecule biologic products, and the research, development, and commercialization of innovative drugs.
heparin industrial chain
an industry leader with vertically integrated capabilities in the global heparin industrial chain business
focused on recombinant and naturally derived large molecule biologics and gene therapy products